Suppr超能文献

免疫抑制性和非免疫抑制性环孢素类似物通过亲环蛋白依赖性抑制钙调神经磷酸酶,对机会性真菌病原体新型隐球菌具有毒性。

Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin.

作者信息

Cruz M C, Del Poeta M, Wang P, Wenger R, Zenke G, Quesniaux V F, Movva N R, Perfect J R, Cardenas M E, Heitman J

机构信息

Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Antimicrob Agents Chemother. 2000 Jan;44(1):143-9. doi: 10.1128/AAC.44.1.143-149.2000.

Abstract

Cyclosporine (CsA) is an immunosuppressive and antimicrobial drug which, in complex with cyclophilin A, inhibits the protein phosphatase calcineurin. We recently found that Cryptococcus neoformans growth is resistant to CsA at 24 degrees C but sensitive at 37 degrees C and that calcineurin is required for growth at 37 degrees C and pathogenicity. Here CsA analogs were screened for toxicity against C. neoformans in vitro. In most cases, antifungal activity was correlated with cyclophilin A binding in vitro and inhibition of the mixed-lymphocyte reaction and interleukin 2 production in cell culture. Two unusual nonimmunosuppressive CsA derivatives, (gamma-OH) MeLeu(4)-Cs (211-810) and D-Sar (alpha-SMe)(3) Val(2)-DH-Cs (209-825), which are also toxic to C. neoformans were identified. These CsA analogs inhibit C. neoformans via fungal cyclophilin A and calcineurin homologs. Our findings identify calcineurin as a novel antifungal drug target and suggest nonimmunosuppressive CsA analogs warrant investigation as antifungal agents.

摘要

环孢素(CsA)是一种免疫抑制和抗菌药物,它与亲环蛋白A结合后可抑制蛋白磷酸酶钙调神经磷酸酶。我们最近发现,新型隐球菌在24摄氏度时对CsA有抗性,但在37摄氏度时敏感,并且钙调神经磷酸酶是其在37摄氏度时生长和致病性所必需的。在此,我们对CsA类似物进行了体外抗新型隐球菌毒性的筛选。在大多数情况下,抗真菌活性与体外亲环蛋白A结合以及细胞培养中混合淋巴细胞反应和白细胞介素2产生的抑制相关。我们鉴定出了两种不同寻常的非免疫抑制性CsA衍生物,即(γ-OH)MeLeu(4)-Cs(211-810)和D-Sar(α-SMe)(3)Val(2)-DH-Cs(209-825),它们对新型隐球菌也有毒性。这些CsA类似物通过真菌亲环蛋白A和钙调神经磷酸酶同源物来抑制新型隐球菌。我们的研究结果确定钙调神经磷酸酶是一种新型抗真菌药物靶点,并表明非免疫抑制性CsA类似物作为抗真菌剂值得研究。

相似文献

8
and Assessment of FK506 Analogs as Novel Antifungal Drug Candidates.并评估 FK506 类似物作为新型抗真菌药物候选物。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01627-18. Print 2018 Nov.

引用本文的文献

9
FKBP Ligands-Where We Are and Where to Go?FKBP配体——我们所处的位置与前进的方向?
Front Pharmacol. 2018 Dec 5;9:1425. doi: 10.3389/fphar.2018.01425. eCollection 2018.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验